Our company

Our specialized and passionate scientific team consistently operates under the latest quality standards to deliver Swiss tailor-made solutions with the final product 100% manufactured in Europe.

Stragen Nordic A/S

Stragen Nordic A/S, as part of the Stragen Group, develops and distributes Stragen generic pharmaceutical products in Scandinavia. Our offices are located in Hillerød, Denmark which is north of Copenhagen, where we have our own registration department and manage our well-established distribution network covering all of the Nordic countries.

Stragen Nordic A/S is a well-established supplier of high-quality medicines. All Stragen Nordic’s production takes place in Europe, ensuring our offering of unsurpassed delivery security and the best possible quality control on all levels.

Eliteleverandør
Our company
our expertise

OUR EXPERTISE

Focusing on innovation for health solutions since 1990, Stragen is a global player in the development, registration and distribution of Generic drugs, Consumer Health products and Original drugs. Starting as a small API trading platform 30 years ago in Geneva, Switzerland, today Stragen operates in over 60 markets through a network of dynamic and collaborative partners, employing over 150 people and working with 10 dedicated affiliates worldwide.

As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we invest in the fundamental research through to the delivery of innovative and trusted health solutions to address unmet medical needs.

We focus on three core activities:

  • Rx Products
  • Consumer Health Products
  • Original Drugs Development

Our specialized and passionate scientific team consistently operates under the latest quality standards to deliver Swiss tailor-made solutions with the final product 100% manufactured in Europe.

At Stragen, we understand that business models need to be reinvented to work within our competitive and fast-changing environment of the Pharma industry. We have identified how we can positively diversify our activities beyond the historical development and licensing out of Generic+ products, to the development of Consumer Health products as well as the development through to proof of concept of patented new drugs.

Innovation

At Stragen, we aspire to be one of the leading innovative partners in health. Innovation is at the heart of everything we do. It is the core function that drives our passionate employees to bring to market high quality innovative drugs and consumer health products. Through our entrepreneurial approach and 30 years of R&D know-how, we have developed a wide range of new products and created opportunities in more than 60 countries.

Years of R&D
Know-How

Worldwide
Affiliates

Market
Authorizations

Operating
Countries

Innovation